Angiogenic peptides improve blood flow and promote capillary growth in a diabetic and ischaemic mouse model

European Journal of Vascular and Endovascular Surgery

Volumn 40, Issue 3, 2010, Pages 381-388

  Raiter, A ^a   Bechor, Z ^a   Kleiman, M ^a   Leshem Lev, D ^a   Battler, A ^b   Hardy, B ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b RABIN MEDICAL CENTER   (Israel)

Author keywords

Angiogenic peptides; Diabetes; Ischaemia; Neo vascularisation

Indexed keywords

BOVINE INSULIN; CASPASE 3; CASPASE 7; GLUCOSE; GLUCOSE REGULATED PROTEIN 78; PEPTIDE ADOPEP1; PEPTIDE DERIVATIVE; PEPTIDE ROY; RECOMBINANT VASCULOTROPIN; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; BLOOD FLOW; BOVINE MASTITIS; CAPILLARY DENSITY; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; ECHOGRAPHY; ENDOTHELIUM CELL; FEMALE; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; HUMAN CELL; LIMB ISCHEMIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STREPTOZOCIN DIABETES;

EID: 78149412231     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2010.02.003     Document Type: Article

References (29)

1. Preis SR, Hwang SJ, Coady S, Pencina MJ, D'Agostino RB, et al. Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham Heart Study, 1950 to 2005. Circulation 2009;119: 1728-35.
2. Lacigova S, Bartunek L, Cechurova D, Visek J, Gruberova J, Krcma M, et al. Influence of cardiovascular autonomic neuropathy on atherogenesis and heart function in patients with type 1 diabetes. Diabetes Res Clin Pract 2009;83:26-31.
3. Novo S, Coppola G, Milio G. Critical limb ischemia: Definition and natural history. Curr Drug Targets 2004;4:219-25. (Pubitemid 39162412)
4. Dormandy A, Rutherford AB. Management of peripheral arterial disease (PAD): TASC working group: TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg 2000;31(pt 2):S1eS296.
5. Lockhart CJ, Hamilton PK, McVeigh KA, McVeigh GE. A cardiologist view of vascular disease in diabetes. Diabetes Obes Metab 2008;10(4):279-92. (Pubitemid 351386025)
6. Mukherjee D. Best practice & research. Clin Endocrinol Metab 2009;23:335-45.
7. Isner JM, Asahara T. Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization. J Clin Invest 1999;103:1231-6. (Pubitemid 29218292)
8. Huang Y, Marui A, Sakaguchi H, Esaki J, Arai Y, Hirose K, et al. Sustained release of prostaglandin -1 potentiates the impaired therapeutic angiogenesis by basic fibroblast growth factor in diabetic murine hindlimb ischemia. Circ J 2008;72(10):1693-9.
9. Risau W. Mechanisms of angiogenesis. Nature 1997;386:671-4. (Pubitemid 27193480)
10. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995;1:27-31.
11. McGinn S, Saad S, Poronnik P, Pollock CA. High glucosemediated effects on endothelial cell proliferation occur via p38 MAP kinase. Am J Physiol Endocrinol Metab 2003;285(4): -708e-717.
12. Lorenzi M, Cagliero E, Toledo S. Glucose toxicity for human endothelial cells in culture: Delayed replication, disturbed cell cycle, and accelerated death. Diabetes 1985;34:621-7. (Pubitemid 15042101)
13. Baumgartner-Parzer SM, Wagner L, Pettermann M, Grillari J, Gessl A, Waldhausl W. High-glucose-triggered apoptosis in cultured endothelial cells. Diabetes 1995;44:1323-7.
14. Ceriello A, Quagliaro L, D'Amico M, Di Filippo C, Marfella R, et al. Acute hyperglycemia induces nitrotyrosine formation and apoptosis in perfused heart from rat. Diabetes 2002;51:1076-82. (Pubitemid 34438352)
15. Nakagami H, Morishita R, Yamamoto K, Yoshimura SI, Taniyama Y, Aoki M, et al. Phosphorylation of p38 mitogenactivated protein kinase downstream of bax-caspase-3 pathway leads to cell death induced by high D glucose in human endothelial cells. Diabetes 2001;50:1472-81. (Pubitemid 32500182)
16. Sheu ML, Ho FM, Yang RS, Chao KF, Lin W, Lin-Shiau SY, et al. High glucose induces human endothelial cell apoptosis through a phosphoinositide 3-kinase-regulated cyclooxygenase-2 pathway. Arterioscler Thromb Vasc Biol 2005;25:539-45. (Pubitemid 40315675)
17. Cai W, Yang X, Pan Q, Gong Q, Mo X, Yang Z, et al. Critical effect of VEGF in the process of endothelial cell apoptosis induced by high glucose. Apoptosis 2008;13:1331-43.
18. Hardy B, Raiter A, Weiss C, Kaplan B, Tenenbaum A, Battler A. Angiogenesis induced by novel peptides selected from a phage display library by screeninghumanvascularendothelial cells under different physiological conditions. Peptides 2007;8:691-701. (Pubitemid 46205004)
19. Hardy B, Battler A, Weiss C, Kudasi O, Raiter A. Therapeutic angiogenesis of mouse hind limb ischemia by novel peptide activating GRP78 receptor on endothelial cells. Biochem Pharmacol 2008;75(4):891-9. (Pubitemid 351174112)
20. Raiter A,Weiss C, Bechor Z, Ben-Dor I, Battler A. A peptide derived from ADAM15 metalloprotease binds GRP78 on endothelial cell membranes to induce Angiogenesis. JVR 2010;47:399-411.
21. Sun Q, Chen RR, Shen Y, Mooney DJ, Rajagopalan S, et al. Sustained vascular endothelial growth factor delivery enhances angiogenesis and perfusion in ischemic hind limb. Pharm Res 2005;25:1110-6. (Pubitemid 41127068)
22. Roguin A, Avivi A, Nitecki S, Rubinstein I, Levy NS, et al. Restoration of blood flow by using continuous perimuscular infiltration of plasmid DNA encoding subterranean mole rat Spalax ehrenbergi VEGF. Proc Natl Acad Sci U S A 2003;100:4644-8. (Pubitemid 36457783)
23. Roguin A, Nitecki S, Rubinstein I, Nevo E, Avivi A, et al. Vascular endothelial growth factor (VEGF) fails to improve blood flow and to promote collateralization in a diabetic mouse ischemic hind limb model. Cardiovasc Diabetol 2003;2:18-24.
24. Rivard A, Silver M, Chen D, Kearney M, Magner M, et al. Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with Adeno-VEGF. Am J Pathol 1999;154(2): 355-63. (Pubitemid 29094086)
25. Arap MA, Lahdenranta J, Mintz PJ, Hajitou A, Sarkis AS, Arap W, et al. Cell surface expression of the stress response chaperone GRP78 enables tumor targeting by circulating ligands. Cancer Cell 2004;6:275-84. (Pubitemid 39222040)
26. Liu C, Bhattacharjee G, Boisvert W, Dilley R, Edgington T. In vivo interrogation of the molecular display of atherosclerotic lesion surfaces. Am J Pathol 2003;163:1859-71. (Pubitemid 37310017)
27. Ohta T, Eguchi R, Suzuki A, Miyakaze S, Ayuzawa R, Kaji K. Hypoxia-induced apoptosis and tube breakdown are regulated by p38 MAPK but not by caspase cascade in an in vitro capillary model composed of human endothelial cells. J Cell Physiol 2007;211(3):673-81. (Pubitemid 46683035)
28. Scarabelli T, Stephanou A, Rayment N, Pasini E, Comini L, Curello S, et al. Apoptosis of endothelial cells precedes myocyte cell apoptosis in ischemia/reperfusion injury. Circulation 2001;104:253-6. (Pubitemid 32666943)
29. Ostergaard L, Simonse U, Eskildsen-Helmond Y, Vorum H, Uldbjerg N, Honore B, et al. Proteomics reveals lowering oxygen alters cytoskeletal and endoplasmatic stress proteins in human endothelial cells. Proteomics 2009;9:457-4467.